Experience of Using Pentosan Polysulfate SP 54 in Patients with Diabetic Foot Syndrome

I.V. Nosenko

Abstract


Diabetic foot — a complex of anatomical and functional changes in the feet caused by diabetic neuropathy leading to osteoarthropathy and angiopathy, against which purulent necrotic processes may develop. Microangiopathy determines basement membrane thickening with deposition in it of PAS-positive substances, endothelial proliferation, leading to circulatory disturbances and, consequently, to the development of thrombosis, embolism, prolonged vasoconstriction. In the treatment for diabetic foot syndrome, heparinoids took leading positions. Application of such heparinoid, as Pentosan polysulfate SP 54, is promising. Its multivector (anticoagulant, fibrinolytic and lipid-lowering) effect on the factor Xa, regardless of antithrombin III, makes it possible to carry out the treatment for diabetic foot syndrome.


Keywords


diabetic foot syndrome; Pentosan polysulfate SP 54



DOI: https://doi.org/10.22141/2224-0721.6.62.2014.76940

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru